ADARx Pharmaceuticals, Inc. (ADRX) FinancialsADRXADARx Pharmaceuticals, Inc.

In the context of the broader market, ADRX competes directly with industry leaders such as HCSG and ICFI. With a market capitalization of $2.05B, it holds a leading position in the sector. When comparing efficiency, ADRX's gross margin of N/A stands against HCSG's 15.89% and ICFI's 34.40%. Such benchmarking helps identify whether ADARx Pharmaceuticals, Inc. is trading at a premium or discount relative to its financial performance.

The company successfully raised $446 million in its IPO, exceeding its initial fundraising goals, which indicates robust market demand for its products.